Search details
1.
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 24(10)2023 May 19.
Article
in English
| MEDLINE | ID: mdl-37240349
2.
A potential osteogenic role for microRNA-181a-5p during palatogenesis.
Eur J Orthod
; 45(5): 575-583, 2023 09 18.
Article
in English
| MEDLINE | ID: mdl-37454242
3.
Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptides.
Prostate
; 82(6): 657-665, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35098567
4.
Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism.
J Urol
; 206(2): 219-228, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33787321
5.
The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.
Int J Mol Sci
; 22(4)2021 Feb 08.
Article
in English
| MEDLINE | ID: mdl-33567533
6.
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
Int J Cancer
; 146(11): 3196-3206, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-31745978
7.
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Clin Chem
; 66(6): 842-851, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32408351
8.
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.
Hum Mol Genet
; 23(20): 5545-57, 2014 Oct 15.
Article
in English
| MEDLINE | ID: mdl-24861552
9.
The role of HOXC6 in prostate cancer development.
Prostate
; 75(16): 1868-76, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26310814
10.
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation.
J Urol
; 193(3): 1023-9, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25242390
11.
TempEasy 3D Hydrogel Coculture System Provides Mechanistic Insights into Prostate Cancer Bone Metastasis.
ACS Appl Mater Interfaces
; 16(20): 25773-25787, 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38739686
12.
TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library.
PLoS One
; 19(2): e0296960, 2024.
Article
in English
| MEDLINE | ID: mdl-38394155
13.
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.
Hum Mol Genet
; 20(21): 4268-81, 2011 Nov 01.
Article
in English
| MEDLINE | ID: mdl-21750109
14.
Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.
Mol Med
; 18: 1449-55, 2013 Jan 22.
Article
in English
| MEDLINE | ID: mdl-23196782
15.
Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?
Int J Mol Sci
; 14(6): 12346-66, 2013 Jun 10.
Article
in English
| MEDLINE | ID: mdl-23752272
16.
Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Oral Oncol
; 137: 106297, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36610231
17.
DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells.
Prostate
; 72(16): 1708-17, 2012 Dec 01.
Article
in English
| MEDLINE | ID: mdl-22473304
18.
Development and characterization of patient-derived salivary gland cancer organoid cultures.
Oral Oncol
; 135: 106186, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36265373
19.
The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer.
Noncoding RNA
; 8(6)2022 Dec 01.
Article
in English
| MEDLINE | ID: mdl-36548180
20.
Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients.
Cancers (Basel)
; 14(17)2022 Aug 27.
Article
in English
| MEDLINE | ID: mdl-36077692